Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Sun, Jingyan ^a   Yu, Jinpu ^a   Li, Hui ^a   Yang, Lili ^a   Wei, Feng ^a   Yu, Wenwen ^a   Liu, Juntian ^a   Ren, Xiubao ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

3 Dioxygenase; breast neoplasms; CHO Cells; immune tolerance; Indoleamine Pyrrole 2; regulatory T Lymphocytes

Indexed keywords

CELL PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 7 RECEPTOR; LIPOCORTIN 5; RNA; TRANSCRIPTION FACTOR FOXP3; TRYPTOPHAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; MESSENGER RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER PATIENT; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CHO CELL; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL DEPLETION; T LYMPHOCYTE; UPREGULATION; WESTERN BLOTTING; ANIMAL; BREAST TUMOR; CELL PROLIFERATION; CRICETULUS; ENZYMOLOGY; GENETICS; HAMSTER; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CRICETULUS; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 80052833629     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-82     Document Type: Article

References (25)

1. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Uyttenhove C, Pilotte L, Theate I, et al. Nat Med 2003 9 1269 74 10.1038/nm934 14502282 (Pubitemid 37279849)
2. Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. Mellor AL, Keskin DB, Johnson T, et al. J Immunol 2002 168 3771 6 11937528 (Pubitemid 34298376)
3. Prevention of allogeneic fetal rejection by tryptophan catabolism. Munn DH, Zhou M, Attwood JT, et al. Science 1998 281 1191 3 9712583 (Pubitemid 28406294)
4. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. Munn DH, Mellor AL, J Clin Invest 2007 117 1147 54 10.1172/JCI31178 17476344 (Pubitemid 46718399)
5. Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer. Astigiano S, Morandi B, Costa R, et al. Neoplasia 2005 7 390 6 10.1593/neo.04658 15967116 (Pubitemid 40664228)
6. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Brandacher G, Perathoner A, Ladurner R, et al. Clin Cancer Res 2006 12 1144 51 10.1158/1078-0432.CCR-05-1966 16489067 (Pubitemid 43342502)
7. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells. Okamoto A, Nikaido T, Ochiai K, et al. Clin Cancer Res 2005 11 6030 9 10.1158/1078-0432.CCR-04-2671 16115948 (Pubitemid 41170335)
8. [Study of indoleamine 2,3-dioxygenase expression in patients with breast cancer]. Sakurai K, Amano S, Enomoto K, et al. Gan To Kagaku Ryoho 2005 32 1546 9 16315864
9. Role of regulatory T cells in human diseases. Chatila TA, J Allergy Clin Immunol 2005 116 949 59 quiz 60 10.1016/j.jaci.2005.08.047 16275360 (Pubitemid 41571772)
10. Natural regulatory T cells and self-tolerance. Schwartz RH, Nat Immunol 2005 6 327 30 10.1038/ni1184 15785757 (Pubitemid 41716768)
11. IDO inhibits T-cell function through suppressing Vav1 expression and activation. Li R, Wei F, Yu J, et al. Cancer Biol Ther 2009 8 1402 8 10.4161/cbt.8.14.8882 19597340
12. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. Curti A, Pandolfi S, Valzasina B, et al. Blood 2007 109 2871 7 17164341 (Pubitemid 46482083)
13. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Mellor AL, Munn DH, Immunol Today 1999 20 469 73 10.1016/S0167-5699(99)01520-0 10500295 (Pubitemid 29476077)
14. CTLA-4-Ig regulates tryptophan catabolism in vivo. Grohmann U, Orabona C, Fallarino F, et al. Nat Immunol 2002 3 1097 101 10.1038/ni846 12368911 (Pubitemid 35363664)
15. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Munn DH, Sharma MD, Baban B, et al. Immunity 2005 22 633 42 10.1016/j.immuni.2005.03.013 15894280 (Pubitemid 40719198)
16. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Grohmann U, Volpi C, Fallarino F, et al. Nat Med 2007 13 579 86 10.1038/nm1563 17417651 (Pubitemid 46828479)
17. Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. Nakamura T, Shima T, Saeki A, et al. Cancer Sci 2007 98 874 81 10.1111/j.1349-7006.2007.00470.x 17433037 (Pubitemid 46691826)
18. Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection. Witkiewicz A, Williams TK, Cozzitorto J, et al. J Am Coll Surg 2008 206 849 54 discussion 54-6 10.1016/j.jamcollsurg.2007.12.014 18471709
19. Indoleamine 2,3-dioxygenase activity and L-tryptophan transport in human breast cancer cells. Travers MT, Gow IF, Barber MC, et al. Biochim Biophys Acta 2004 1661 106 12 10.1016/j.bbamem.2003.12.004 14967480 (Pubitemid 38201576)
20. Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer. Mansfield AS, Heikkila PS, Vaara AT, et al. BMC Cancer 2009 15 231
21. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. Sharma MD, Baban B, Chandler P, et al. J Clin Invest 2007 117 2570 82 10.1172/JCI31911 17710230 (Pubitemid 47494358)
22. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. Munn DH, Sharma MD, Hou D, et al. J Clin Invest 2004 114 280 90 15254595 (Pubitemid 39071633)
23. [Measurement of CD4+CD25+ T cells in breast cancer patients and its significance]. Liu JT, Yue J, Ren XB, et al. Zhonghua Zhong Liu Za Zhi 2005 27 423 5 16188129
24. Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Larmonier N, Marron M, Zeng Y, et al. Cancer Immunol Immunother 2007 56 48 59 16612596 (Pubitemid 44812446)
25. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Puccetti P, Grohmann U, Nat Rev Immunol 2007 7 817 23 10.1038/nri2163 17767193 (Pubitemid 47480306)